Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Explore when to make changes to your spending plan and how to rebalance categories so you stay aligned with goals and cash flow.
23,566 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Ford and GM are reshaping their business models by moving into energy-related assets like batteries, charging network...
NextEra Energy moves to acquire Dominion’s Virginia franchise in a $66.8 billion all-stock deal, spotlighting the gri...
For the first time ever, Citi Wealth notes a surge in ultrawealthy U.S. clients seeking cross-border diversification ...
A rare public reversal from Elon Musk shines a light on Anthropic as a leading AI player. For Amazon and Alphabet inv...
Accelerant Holdings has fallen sharply since its IPO, but a major fund just took a sizable stake. This article explai...
Snap Inc has faced a severe share-price drop, but a mix of AR hardware progress, AI-enhanced ads, and international g...
Regulatory rhetoric around the Clarity Act ignites a fresh XRP debate, with Cardano founder Charles Hoskinson warning...
Learn the core ideas behind a monster stock hold next five years and how patient investors can use a disciplined plan...
$200K earner ditches roth to cut college costs by lowering AGI for aid calculations at elite universities. The move h...
Nearly half of U.S. homeowners paused moving plans in the last year, a sign that housing market inertia grows even as...
Oxbridge Re kicks off 2026 with a Q1 that mixes solid underwriting with measured investment moves. This deep dive exp...